Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Halabi

Showing results (131-140 of 282) with videos related to

Pageof 29
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II studyBrian I Rini, Susan Halabi, Robert Barrier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer--a Cancer and Leukemia Group B studyRobert W Ross, Susan Halabi, San-San Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2007
American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myelomaRobert A Kyle, Gary C Yee, Mark R Somerfield, et al.
European Urology Oncology|August 27, 2021
Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation PanelBrandon A Mahal, Travis Gerke, Shivanshu Awasthi, et al.
Clinical Genitourinary Cancer|July 9, 2013
A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancerAndrew J Armstrong, Tong Shen, Susan Halabi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancerJoellen M Schildkraut, Susan K Murphy, Rachel T Palmieri, et al.
Clinical Genitourinary Cancer|October 1, 2008
A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004Nancy A Dawson, Susan Halabi, San-San Ou, et al.
Ebiomedicine|February 13, 2016
A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance)Hyung L Kim, Susan Halabi, Ping Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480Eric J Small, Susan Halabi, Mark J Ratain, et al.
BMJ Open|August 31, 2025
Design aspects for prognostic factor studiesPeggy Sekula, Inga Steinbrenner, Ulla T Schultheiss, et al.
Pageof 29

Showing results (131-140 of 282) with videos related to

Sort By:
Pageof 29
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II studyBrian I Rini, Susan Halabi, Robert Barrier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer--a Cancer and Leukemia Group B studyRobert W Ross, Susan Halabi, San-San Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2007
American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myelomaRobert A Kyle, Gary C Yee, Mark R Somerfield, et al.
European Urology Oncology|August 27, 2021
Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation PanelBrandon A Mahal, Travis Gerke, Shivanshu Awasthi, et al.
Clinical Genitourinary Cancer|July 9, 2013
A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancerAndrew J Armstrong, Tong Shen, Susan Halabi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancerJoellen M Schildkraut, Susan K Murphy, Rachel T Palmieri, et al.
Clinical Genitourinary Cancer|October 1, 2008
A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004Nancy A Dawson, Susan Halabi, San-San Ou, et al.
Ebiomedicine|February 13, 2016
A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance)Hyung L Kim, Susan Halabi, Ping Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480Eric J Small, Susan Halabi, Mark J Ratain, et al.
BMJ Open|August 31, 2025
Design aspects for prognostic factor studiesPeggy Sekula, Inga Steinbrenner, Ulla T Schultheiss, et al.
Pageof 29